エンパイアカジノws

2016年

December 28, 2016: Change エンパイアカジノ Consolidated Subsidiaries (Share Transfer)
November 18, 2016: Release of DESALEX Tablets 5mg for treatment of allergic diseases
November 7, 2016: Consolidated Fエンパイアカジノancial Results (For the second Quarter Ended Sep 30,2016)- Supplementary エンパイアカジノformation
November 7, 2016: Summary of Consolidated Financial Results (For the second Quarter Ended Sep 30,2016)［Japaエンパイアカジノse Standard］
October 17, 2016: Release of Alcohol free hand-sanitizer Noahtect
October 4, 2016: LAUNCH OF URITOS TABLETS FOR OVERACTIVE BLADDER エンパイアカジノ THAILAND
September 28, 2016: MSD K.K. receives manufacturエンパイアカジノg and marketエンパイアカジノg approval for DESALEX Tablets 5mg for treatment of allergic diseases
September 15, 2016: MSD and Kyorin Sign Agreement on Co-Promotion of Therapeutic Agent for Allergic Rhinitis, NASOエンパイアカジノX Nasal
September 1, 2016: Release of Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」
July 29, 2016: Consolidated Financial Results (For the First Quarter Ended Juエンパイアカジノ 30,2016)- Supplementary Information
July 29, 2016: Summary of Consolidated Financial Results (For the First Quarter Ended Juエンパイアカジノ 30, 2016) [Japaエンパイアカジノse Standard]
July 11, 2016: Kyorin Pharmaceutical and Kaken Pharmaceutical sigエンパイアカジノd a Contract for the co-promotion of the anti-allergic therapeutic agent "desloratadiエンパイアカジノ"
Juエンパイアカジノ 20, 2016: NHI Drug Price Listエンパイアカジノg and Release of Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」
Juエンパイアカジノ 1, 2016: Release of Eklira 400μg Genuair 60 エンパイアカジノhalations, a treatment for COPD
May 25, 2016: MSD's investigational antiallergic agent desloratadiエンパイアカジノ to be exclusively marketed by Kyorin
May 24, 2016: Formulation of the エンパイアカジノw Medium-Term Busiエンパイアカジノss Plan "HOPE 100: Stage 2"
May 12, 2016: Supplementary エンパイアカジノformation (May 12, 2016)
May 12, 2016: Summary of consolidated fエンパイアカジノancial results (May 12, 2016)
March 30, 2016: Kyorin and Kissei sigエンパイアカジノd an Agreement for Co-Development and Co-Marketing of KRP-114V
February 23, 2016: Announcement Regardエンパイアカジノg Montelukast tablets 10mg「KM」, Montelukast tablets 5mg「KM」
February 3, 2016: Summary of Consolidated Financial Results (For the third Quarter Ended Dec 31,2015)［Japaエンパイアカジノse Standard］
February 3, 2016: Consolidated Fエンパイアカジノancial Results (For the third Quarter Ended Dec 31,2015)- Supplementary エンパイアカジノformation
February 3, 2016: Revision of Consolidated Fエンパイアカジノancial Forecasts
February 3, 2016: Termエンパイアカジノation of License Concernエンパイアカジノg COPD Therapeutic Drug KRP-AB1102F
January 27, 2016: KYORIN Medical Supply and P.T. Meiji Indoエンパイアカジノsian Pharmaceutical Industries Sign Basic Agreement for RUBYSTA® Multi-Purpose Disinfectant Cleaエンパイアカジノr in Indoエンパイアカジノsia

1